In response to the delisting notice, Cambium Networks is considering whether to appeal the decision to the Nasdaq Listing and Hearing Review Council. However, it is important to note that such an appeal would not halt the suspension of trading. Following the delisting, the company expects its ordinary shares to transition to the OTC Pink Limited tier and subsequently into the Expert Market under the trading symbol 'CMBM'. This change in trading venues may significantly impact the liquidity and trading volume of Cambium's shares, potentially leading to increased price volatility and reduced transparency for investors.
The company issued a press release on March 26, 2026, to announce the receipt of the delisting determination and to clarify the expected changes in trading status. The press release emphasized that the amendment to the previous filing was solely to correct the initial miscommunication regarding the trading status of the ordinary shares, which was incorrectly stated to be available for quotation on the OTCID market. The amendment does not alter any previously reported information contained in the original Form 8-K.
Investors are advised to consider the implications of this delisting and the potential challenges in trading the company's shares on the new platforms. The company’s future compliance with Nasdaq's listing standards remains uncertain, and shareholders may find it more difficult to buy or sell their shares in the new trading environment.
